Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer: Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical Trial

Por Chu, Michael P., Hecht, J. Randolph, Slamon, Dennis, Wainberg, Zev A., Bang, Yung-Jue, Hoff, Paulo M., Sobrero, Alberto, Qin, Shukui, Afenjar, Karen, Houe, Vincent, King, Karen, Koski, Sheryl, Mulder, Karen, Hiller, Julie Price, Scarfe, Andrew, Spratlin, Jennifer, Huang, Yingjie J., Khan-Wasti, Saba, Chua, Neil, Sawyer, Michael B.
Publicado no JAMA Oncol (2016)

Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study

Por Hurvitz, Sara A., Martin, Miguel, Jung, Kyung Hae, Huang, Chiun-Sheng, Harbeck, Nadia, Valero, Vicente, Stroyakovskiy, Daniil, Wildiers, Hans, Campone, Mario, Boileau, Jean-François, Fasching, Peter A., Afenjar, Karen, Spera, Gonzalo, Lopez-Valverde, Vanesa, Song, Chunyan, Trask, Peter, Boulet, Thomas, Sparano, Joseph A., Symmans, W. Fraser, Thompson, Alastair M., Slamon, Dennis
Publicado no J Clin Oncol (2019)